| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > Selling Slumps, How to Pull Out Before You Crash and Burn Tip 4 |
|
Useful Advices - Selling Slumps, How to Pull Out Before You Crash and Burn Tip 4
It matters very little whether you are a selling rookie or a seasoned professional, sooner or later, you wil According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product l find yourself mired in a selling slump. There are a number of actions you can take to shorten the duration ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in of the slump, lessen the financial impact and reduce the emotional drain that a slump can cause you. This is lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. 'Tip 4' in a series. Selling slumps are as perennial as the seasons but they don't need t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe destroy your career. Understand that they are part of the marketplace and they always will be. They are cau d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ed by a variety of factors but always keep in mind that you didn't just wake up 'dumb' one morning. When you ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc understand that fact, it will be easier to recognize that the situation is temporary. In old writings autho easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s often used the term, "it came to pass". They didn't use the term, "it came to stay". nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Tip #4: Develop empathy so you are able to transition from trying to convince your prospect to probl and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ m solving for him or her. Many salespeople feel that they must convince prospects to buy their prod ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ct or service offer. The truth is that people will ultimately choose to buy what they feel they want, need a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nd can afford. If your product or service has sufficient benefits, the customer will choose to buy from you. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod To easily allow the sale to develop you will need to come from a position of empathy where you allow yourse cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin lf to discover the underlying buying motives of your prospect. Once you have identified these triggers, rath tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen r than going into 'convince mode' try involving your customer and focus on 'reveali t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel g' the benefits the customer will enjoy when he or she takes ownership of your product or service. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust It can tip the scales in your favor if you are able to reveal a particular extra benefit that the prospect w y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sn't expecting. Layered benefits increase value and reduce price resistance. When salespeople spend their t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ime 'convincing' they are often seen as pressuring. When they are'revealing' elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip > benefits, they are seen as helpful and the prospect is much more likely to make a positive buying decision tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Design For Banking Privacy-Agency Branch Banking A Time to Focus and a Time to Diversify
|